Nov 8, 2006


Nathan Klein is the first person in the world to receive gene therapy in the brain to reduce the devastating effects of this disease. This research represents a significant step towards refining effective gene therapies to treat not only Parkinson's, but other neurological disorders – and could someday offer new hope to others with this debilitating disease. With over 700 ongoing clinical trials, NewYork-Presbyterian Hospital and the medical colleges of Weill Cornell and Columbia University collaborate to find answers that enhance and save lives. NewYork-Presbyterian is one of only five hospitals in the country ranked in all 16 specialties reviewed by U.S.News & World Report. To learn more, call 877-NYP-WELL, or visit Don't you deserve this level of care?